Updated Date: Thu, 09 Dec 2021 00:00:00 EST
Gilead’s Yescarta in line for $1.5B sales in earlier lymphoma thanks to game-changing data, fast production turnaround: analyst […]
A view to brevity: Brand Institute’s clear-eyed approach to naming AbbVie’s new eyesight drug Vuity badams Thu, 12/16/2021 […]
Scientists have spotted signs of ‘pre-resistance’ in bacteria for the first time — signs that particular bacteria are […]
Some 800 000 Americans have died from covid-19, the highest number of any country in the world, and […]
What you need to knowThe nature and scale of a participant’s personal investment in clinical trials needs to […]
“I, a reasoning being, am capable of deducing truth from a priori causes. You, being intelligent but unreasoning, […]
How to donatePlease give generously to The BMJ’s appeal for 2021-22. Donations can be made atmsf.org.uk/bmjThe 2021-22 appeal […]
The emergence of the omicron variant of covid-19 serves as a stark reminder that while we have made […]
Venetoclax is an oral once-daily treatment, which blocks the action of the B-cell lymphoma-2 protein, the presence of […]